TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PRTA

Prothena Corporation plc

Healthcare · Biotechnology

8.50$ -0.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Prothena Corporation plc (PRTA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 303 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PRTA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
747 696 623 646 595 547 495 399 353 327 350 303
691 639 566 586 535 485 436 385 340 315 339 292
671 619 547 564 519 471 418 371 331 308 329 288
671 619 547 564 519 471 418 371 331 308 329 288
5.2 5.2 0.0 0.0 0.0 0.0
11 -5.2
15
130 135 121 64 61 60 58 75 58 46 37 16
53 57 43 47 46 49 48 68 51 41 33 12
1.8 1.1 2.4 2.6 2.6 2.6 2.6 2.9 2.9 2.9 2.9 3.0
19 25 14 9.3 10 7.8 16 12 11 5.9 4.3 1.9
617 561 502 582 534 487 438 324 295 280 313 287
-913 -980 -1,052 -985 -1,044 -1,102 -1,163 -1,288 -1,325 -1,346 -1,314 -1,332
58 54 54 55 54 54 54 54 54 54 54 52

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?